Urinary enzyme measurements as early indicators of renal insult in type 2 diabetes

British Journal of Biomedical Science

Volumn 64, Issue 4, 2007, Pages 153-156

  Kalansooriya, A ^a   Jennings, P ^b   Haddad, F ^b   Holbrook, I ^b   Whiting, P H ^a  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

^b YORK HOSPITAL   (United Kingdom)

Author keywords

Diabetic nephropathies; Enzymuria; Glutathione transferase

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; BIOCHEMICAL MARKER; CREATININE; GLUTATHIONE TRANSFERASE ALPHA; GLUTATHIONE TRANSFERASE P1; MICROSOMAL AMINOPEPTIDASE; N ACETYL BETA GLUCOSAMINIDASE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ASSAY; GLOMERULUS FILTRATION; HUMAN; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

EID: 37849031598     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2007.11732778     Document Type: Article

References (30)

1. Panchapakesan U, Xin-Ming C, and Pollock CA. Drug insight: thiazolidinediones and diabetic nephropathy - relevance to renoprotection. Nat Clin Pract Nephrol 2005; 1: 33-43.
2. Mogenson CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. Diabetes 1993; 32: 64S-78S.
3. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent diabetic patients. N Engl J Med 1984; 311: 89-93.
4. Friedman EA, Friedman AL. Is there really good news about pandemic diabetic nephropathy? Nephrol Dial Transplant 2007; 22: 681-3.
5. Perrone RD, Madias NE, Levy AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: 1933-53.
6. Turner RC. The UK Prospective Diabetes Study: a review. Diabetes Care 1998; 15 (Suppl 4): S47-S50.
7. Whiting PH, Price RG. Importance of early detection of renal dysfunction: value of markers of early renal disease and damage. Clin Biochem 2001; 3: 3-8.
8. Jung K, Pergande M, Schimke E, Ratzman KP, Illus A. Urinary enzymes and low molecular mass protein as indicators of diabetic nephropathy. Clin Chem 1988; 34: 544-77.
9. Uslu S, Efe B, Alatas O et al. Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients. J Nephrol 2005; 18: 559-67.
10. Price RG, Whiting PH. Urinary enzymes and nephrotoxicity in humans. In: Jung K, Matternheimer H, Burchards U eds. Urinary enzymes. Heidelberg: Springer-Verlag, 1992: 203-21.
11. Whiting PH, Ross IS, Borthwick L. Serum and urine N-acetyl-β- D-glucosaminidase in diabetics on diagnosis and subsequent treatment, and stable insulin-dependent diabetics. Clin Chim Acta 1979; 92: 459-63.
12. Watts GF, Vltos MA, Morris RW, Price RG. Urinary N-acetyl-beta-D- glucosaminidase excretion in insulin-dependent diabetes mellitus: relation to microalbuminuria, retinopathy and glycaemic control. Diabetes Metab 1988; 14: 653-8.
13. Nakamura S. Clinical evaluation of urinary alanine aminopeptidase in the patients with diabetes mellitus - comparison among AAP, microalbumin and N-acetyl-β-D-glucosaminidase (Japanese). Hokkaido Igaku Zasshi 1991; 66: 522-33.
14. Jones AP, Lock S, Griffiths KD. Urinary N-acetyl-beta-glucosaminidase activity in type 1 diabetes mellitus. Ann Clin Biochem 1995; 32: 58-62.
15. Koh KTC, Chia KS, Tan C. Proteinuria and enzymuria in non-insulin-dependent diabetics. Diabetes Res Clin Pract 1993; 20: 215-21.
16. Hong C-Y, Hughes K, Chia K-S, Ng V, Ling S-L. Urinary α1-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in Singapore. Diabetes Care 2003; 26: 338-42.
17. Aksun SA, Özmen, Özmen B et al. β2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy. Exp Clin Endocrinol Diabetes 2004; 112: 195-200.
18. Whiting PH, Ross IS, Borthwick. N-acetyl-β-D-glucosaminidase levels and the onset of diabetic microangiopathy. Ann Clin Biochem 1983; 20: 15-9.
19. Branten AJ, Mulder TP, Peters WH, Assmann KJ, Wetzels JF. Urinary excretion of glutathione S transferase alpha and pi in patients with proteinuria: reflection of the site of tubular injury. Nephron 2000; 85: 120-6.
20. Harrison DJ, Kharbanda R, Cunningham DS, McLellan, Hayes LI. Distribution of glutathione S-transferase isoenzymes in human kidney: basis for possible markers of renal injury. J Clin Pathol 1989; 42: 624-8.
21. Shaw M. The use of histologically defined specific biomarkers in drug development with special reference to the glutathione transferases. Cancer Biomark 2005; 1: 69-74.
22. Pergande M, Jung K, Precht S, Fels LM, Herbort C, Stolte H. Changed excretion of urinary proteins and enzymes by chronic exposure to lead. Nephrol Dial Transplant 1994; 9: 613-8.
23. Kurrle-Weittenhiller A, Engel W. Immunoturbidometric determination of urinary α1-microglobulin on Hitachi analysers. Clin Chem 1992; 38: 1090-1.
24. Sánchez-Hueso MC, Mateo-Caãs J, Zamora-Madaria E. Influence of glycaemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetylglucosaminidase (NAG) in diabetes mellitus (Spanish). An Med Interna 1995; 12: 216-20.
25. Watts GF, Vlitos MA, Morris RW, Price RG. Urinary N-acetyl-beta-D- glucosaminidase excretion in insulin-dependent diabetes mellitus: relation to microalbuminuria, retinopathy and glycaemic control. Diabetes Metab 1988; 14: 653-8.
26. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.
27. Nishikawa T, Eidelskein D, Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int 2000; 71: S26-S30.
28. Nishikawa T, Araki E. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal 2007; 9: 343-53.
29. Fujita H, Haseyama T, Kayo T et al. Increased expression of glutathione S-transferase in renal proximal tubules in the early stages of diabetes: a study of type-2 diabetes in the Akita mouse model. Exp Nephrol 2001; 9: 380-6.
30. VanderJagt DJ, Harrison JM, Ratliff DM, Hunsaker LA, Vander Jagt DL. Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin Biochem 2001; 34: 265-70.